altman los alamos

...

Monica Sager

By Monica Sager

Live News Reporter

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


OpenAI has announced a first-of-its-kind partnership with one of the U.S.'s leading national laboratories to study how artificial intelligence can be used safely in an active lab setting.

Sam Altman's organization will work with the Los Alamos National Laboratory, the New Mexico lab where Robert Oppenheimer and his team developed the first nuclear bomb as part of the Manhattan Project.

The partnership, announced in an OpenAI press release Wednesday, is intended to leverage generative AI to "multiply the speed and impact of science for good."

Read More on News

altman los alamos

...

Scientists at Los Alamos will use OpenAI's LLMs, like ChatGPT-4o, to decide where the technology can help in their research, and also to experiment with how the AI can assist "both experts and novices" in the lab.

"This partnership follows a long tradition of the U.S. public sector, and in particular the national labs, working with the U.S. private sector to ensure advances in innovation translate to advancements in essential areas like health care and bioscience," the press release states.

Los Alamos is one of the 16 research and development laboratories within the U.S. Department of Energy. While best known as the birthplace of the atomic bomb, the lab today focuses on everything from national security, nuclear fusion, renewable energy, medicine and nanotechnology.

The partnership comes in the wake of an executive order from the White House last year that pushes for national labs to evaluate the capabilities of using AI within their biological research.

Los Alamos National Laboratory

...

OpenAI's technology is already been used by other leaders in bioscience. Moderna, the mRNA pioneer behind one of the Covid vaccines, is using OpenAI tools to augment clinical trial developments by adding an assistant that will analyze large data sets.

Color Health, which focuses on early cancer detection and comprehensive management, has also built a new copilot using ChatGPT-4o. The AI helps healthcare providers make evidence-based decisions about cancer screening and treatment.

Do you have a story we should be covering? Do you have any questions about Sam Altman and OpenAI? Contact LiveNews@newsweek.com.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines